Brent Hanks

Cancer patients said the COVID-19 pandemic heightened infection concerns, increased feelings of fear, and disrupted their care.

Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured in the media, trades, journals, at Duke and the DCI blog.

Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured in the media, trades, journals, at Duke and the DCI blog.

DCI researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire.

Brent Hanks, MD, PhD, and his lab team will trial a drug that targets the NLRP3 pathway, so as to unblock immunotherapy from working in melanoma patients.

Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured in the media, trades, journals, at Duke and the DCI blog.

Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured by the media, academic trade publications & journals.

The Eighth Annual DCI Scientific Retreat was one for the books.

A decade since the first drug, an immunotherapy, was approved to treat metastatic melanoma, a leading clinician researcher goes head to head with melanoma brain metastasis.

Brent Hanks, MD, PhD, received the Conquer Cancer- Bristol-Myers Squibb Advanced Clinical Research Award in Immune Checkpoint Therapy.

A breast cancer researcher's study of estrogen action may lead to better treatments for other cancers.

Here are some of the DCI faculty, researchers and nurses whose work has recently been featured by the media, academic trade publications & journals.

Brent Hanks, MD, PhD, was named associate director of Translational Science for the Melanoma Disease Group this month.

Duke Cancer Institute will present more than 100 abstracts across multiple cancer types during the ASCO20 Virtual Scientific Program of the 2020 ASCO Annual Meeting.

Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.

The research team found a signaling pathway within melanoma and other cancers that thwart the functioning of anti-PD-1 checkpoint inhibitors.

Translating Findings from a lab into patients in a clinic can be a long slog up a steep hill. The new DCI Center for Cancer Immunotherapy helps researchers with the climb.

Stephen Totty though he had simply pulled a pectoral muscle while moving furniture. But the soreness lingered. Then a painful “water balloon” full of blood developed.

Can research make immunotherapies work better, for more people?

Duke alumnus Ross Bierkan has long supported his alma mater. But his support of melanoma research at Duke is motivated by personal experience.

Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.